|Articles|September 21, 2011
Podcast: The Case for Upgrading existing HPLC Assays to UPLC
Advertisement
Eric Hill of Impact Analytical discusses the emergence new analytical technologies, specifically UPLC. He outlines the advantages of converting existing HPLC assays to UPLC, including both increased performance and cost savings. With minimal upfront investment, the long term gains are significant.
Add this Podcast feed to your media player
WHITEPAPERS
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
2
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
3
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
4
Integrated Digital Workflow Essential in 2026
5